Clinical Trial Update: A Multi-Center Environmental Study for the Treatment of Moderate to Severe Ocular Allergic Conjunctivitis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for a multi-center environmental treatment of moderate to severe ocular allergic conjunctivitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Snippet

Sponsor: Eleven Biotherapeutics | Conditions: Allergic Conjunctivitis (AC) | Phase 3 | Status: COMPLETED